Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.74M Buy
4,801
+84
+2% +$28.8K 0.22% 35
2026
Q1
$1.66M Buy
4,717
+79
+2% +$28.2K 0.21% 32
2025
Q4
$1.52M Buy
4,638
+28
+0.6% +$8.88K 0.21% 33
2025
Q3
$1.3M Buy
4,610
+319
+7% +$92.5K 0.17% 38
2025
Q2
$1.2M Buy
4,291
+662
+18% +$188K 0.15% 35
2025
Q1
$1.13M Buy
3,629
+290
+9% +$85.6K 0.15% 33
2024
Q4
$870K Buy
3,339
+150
+5% +$44.5K 0.12% 39
2024
Q3
$1.03M Buy
3,189
+42
+1% +$13.7K 0.15% 34
2024
Q2
$983K Sell
3,147
-184
-6% -$54.1K 0.15% 30
2024
Q1
$947K Buy
3,331
+37
+1% +$10.8K 0.17% 32
2023
Q4
$949K Buy
3,294
+73
+2% +$19.9K 0.18% 28
2023
Q3
$866K Buy
3,221
+330
+11% +$82.4K 0.2% 26
2023
Q2
$642K Buy
2,891
+247
+9% +$57.3K 0.15% 39
2023
Q1
$639K Sell
2,644
-95
-3% -$23.3K 0.16% 35
2022
Q4
$719K Sell
2,739
-181
-6% -$48.5K 0.2% 30
2022
Q3
$658K Buy
2,920
+93
+3% +$22.5K 0.19% 32
2022
Q2
$688K Sell
2,827
-81
-3% -$19.8K 0.19% 36
2022
Q1
$703K Buy
2,908
+121
+4% +$27.8K 0.17% 34
2021
Q4
$627K Buy
2,787
+757
+37% +$160K 0.15% 41
2021
Q3
$432K Buy
2,030
+130
+7% +$29.9K 0.12% 60
2021
Q2
$463K Buy
1,900
+168
+10% +$41.3K 0.14% 59
2021
Q1
$431K Buy
1,732
+30
+2% +$7.16K 0.16% 50
2020
Q4
$391K Buy
+1,702
New +$392K 0.13% 52

Other funds holding AMGN

Emerald Advisors's AMGN Position: Q2 2026 in Review

Emerald Advisors increased its Amgen (AMGN) stake by 1.8% in Q2 2026, buying an estimated $28.8K and bringing the position to 4,801 shares worth $1.74M. The position accounts for 0.22% of the portfolio, ranked #35.

Emerald Advisors first reported a position in AMGN in Q4 2020 and has held it in 23 quarters since. 1,543 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Emerald Advisors held 4,801 shares of Amgen worth $1.74M as of Q2 2026.
  • Emerald Advisors bought 84 Amgen shares in Q2 2026, an estimated $28.8K.
  • Amgen made up 0.22% of Emerald Advisors's portfolio in Q2 2026, its #35 holding.
  • Emerald Advisors first reported a position in Amgen in Q4 2020 and has held it in 23 quarters since.
  • 1,543 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Emerald Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.